Complementary and alternative medicine use in patients before and after a cancer diagnosis von Buckner, C A, Lafrenie, R M, Dénommée, J A, Caswell, J M, Want, D A

Volltext

Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer von Young, S D, Lafrenie, R M, Clemons, M J

Volltext

Walker 256 Tumor Cell Degradation of Extracellular Matrices Involves a Latent Gelatinase Activated by Reactive Oxygen Species von Shaughnessy, S.G., Whaley, M., Lafrenie, R.M., Orr, F.W.

Volltext

Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression if IL-1β and TNF-α von Allen-Hall, L, Cano, P, Arnason, J.T, Rojas, R, Lock, O, Lafrenie, R.M

Volltext

The relative roles of vitronectin receptor, E-selectin and α4β1 in cancer cell adhesion to interleukin-1-treated endothelial cells von Lafrenie, R.M., Gallo, S., Podor, T.J., Buchanan, M.R., Orr, F.W.

Volltext

Soluble Fas (CD95) is a prognostic factor in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous stem cell transplantation von Bewick, M, Conlon, M, Parissenti, A M, Lee, H, Zhang, L, Glück, S, Lafrenie, R M

Volltext